Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

Rhea-AI Summary

Intelligent Bio Solutions Inc. (INBS) announces participation in the LD Micro Invitational XIV Investor Conference on April 8-9, 2024. President and CEO, Harry Simeonidis, and CFO, Spiro Sakiris, will present the company's non-invasive testing solutions.

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that President and CEO, Harry Simeonidis, and CFO, Spiro Sakiris, are scheduled to present at the LD Micro Invitational XIV Investor Conference to be held on April 8-9, 2024 in New York City.

LD Micro Invitational XIV Investment Conference
Dates: April 8-9, 2024
Location: Sofitel New York, NYC
Presentation: 12:00 p.m. ET on April 9, 2024
Webcast: https://ldinv14.sequireevents.com/

Management will be available during the event for 1x1 meetings with the investment community. To schedule a meeting please reach out to your LD Micro representative or KCSA Strategic Communications by emailing INBS@kcsa.com.

About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company's biosensor platform has the potential to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases. The Company's current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

For more information, visit: http://www.ibs.inc/

Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter

Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com

FAQ

What event is Intelligent Bio Solutions Inc. (INBS) participating in?

INBS is participating in the LD Micro Invitational XIV Investor Conference.

Who will be presenting at the conference from INBS?

President and CEO, Harry Simeonidis, and CFO, Spiro Sakiris, will be presenting at the conference.

When will the presentation take place?

The presentation is scheduled for 12:00 p.m. ET on April 9, 2024.

Where will the LD Micro Invitational XIV Investor Conference be held?

The conference will take place at Sofitel New York, NYC.

How can investors schedule meetings with INBS management during the event?

Investors can schedule meetings by reaching out to their LD Micro representative or KCSA Strategic Communications via email at INBS@kcsa.com.